- 1、本文档共50页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
German Hodgkin Study Group
Deutsche Hodgkin Studiengruppe
Recent Advances in the Treatment of
Hodgkin Lymphoma
Andreas Engert, MD
Chairman, German Hodgkin Study Group
University Hospital of Cologne
Recent Advances
in the Treatment of Hodgkin Lymphoma
• Background
• First-line
• Relapse, New Drugs
• Summary
Hodgkin Lymphoma
Cumulative relativ survival of HL pts in Sweden
Courtesy of Magnus Björkholm 2010
Hodgkin Lymphoma
Late side effects after treatment
• 2nd NPL AML
NHL
Solid tumours
• Organ damage Lung
Heart
Thyroid
• Others Fertility
OPSI
Fatigue
Psycho-social
Hodgkin Lymphoma Management
Considerations for Individual Treatment
Highest Cure Rate Fewest Complications
with Primary for Optimal
Therapy Survivorship
Survivorship starts with initial treatment selection.
Courtesy of Sandra Horning 2007
Recent Advances
in the Treatment of Hodgkin Lymphoma
• Background
• First-line
• Relapse, New Drugs
• Summary
HL risk groups (GHSG)
• Early favorable stages: CS I/II without risk factors*
• Earl
文档评论(0)